Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

P. Merle, J.-F. Blanc, J.-M. Phelip, G. Pelletier, J.-P. Bronowicki, Y. Touchefeu, G. Pageaux, R. Gerolami, F. Habersetzer, E. Nguyen-Khac, A. Casadei-Gardini, I. Borbath, A. Tran, H. Wege, A.S. Saad, M. Colombo, A. Abergel, C. Richou, I. Waked, N.S. YeeA. Molé, P. Attali, J. Le Boulicaut, B. Vasseur, D. Moussata, J.-D. Grangé, V. Ratziu, F. Khemissa-Akouz, H. Regnault, B. Dauvois, J.-P. Zarski, I. Ollivier-Hourmand, S. Manfredi, M. Debette-Gratien, A. Gangloff, T. Fontanges, A. Baron, M. Bouattour, J. Vincent, W. Sieghart, A. Maieron, M. Peeters, J. Delwaide, L. Lasser, T. Berg, M. Schultheiß, A. Zipprich, J. Trojan, U. Ehmer, G. Luppi, G. Luca, S. Tamberi, D. Amoroso, O. Alabiso, A. Buonadonna, P. Toniutto, E. Tamburini, A. Cubillo, A. Muñoz, C. Guillén, G. Sánchez, H. Manzano, V. Navarro, I. Ales, B. Massuti, M. Dank, G. Bodoky, Z. Kahan, Z. Horváth, N. Gabrail, H. Ozer, C. Galanopoulos, R. Hauke, M. Raj, H. Harputluoglu, A. Sevinc, E. Goker, A. Coker, S. Yalcin, M. Ali, O. Ata, I. Tugba, M. ElKassas, A. Abdel, I. Wakid, S. Shamaa, N. El, H. Kohail, J. Makarem, I. Chehade, F. Farhat, C. López, M. Marín

Research output: Contribution to journalArticle

Cite this

Merle, P., Blanc, J-F., Phelip, J-M., Pelletier, G., Bronowicki, J-P., Touchefeu, Y., Pageaux, G., Gerolami, R., Habersetzer, F., Nguyen-Khac, E., Casadei-Gardini, A., Borbath, I., Tran, A., Wege, H., Saad, A. S., Colombo, M., Abergel, A., Richou, C., Waked, I., ... Marín, M. (2019). Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial. The Lancet Gastroenterology and Hepatology, 4(6), 454-465. https://doi.org/10.1016/S2468-1253(19)30040-8